Roche expands hepatitis diagnostics portfolio

Almost 300 million people globally have chronic hepatitis B

Roche launches Elecsys HCV Duo immunoassay for hepatitis C virus

Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.

Saraq Hepatitis C kit receives CDSCO nod

The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth

VBI’s 3-antigen Hepatitis B vaccine gets CHMP nod

If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.

ASMS explores strategic research collaboration with Mediciti Institute

Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings

Novo Nordisk unveils breakthrough MASH data as ‘silent’ liver disease threatens 250 million

Cupid shatters FY26 guidance with record 93% revenue jump & 165% profit surge

Growth was driven by expansion across key business segments, improving efficiencies, and sustained demand across institutional and retail channels

Gilead posts solid Q1 2026 growth & raises full-year outlook on HIV momentum

Energy drinks emerging as hidden driver of liver damage in India’s youth, warn experts

Medical experts point to a growing body of research linking energy drinks to liver injury

Kolkata gets advanced liver care hub as Manipal Hospitals targets critical treatment gap

The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network